Stockreport

Co-Diagnostics Second Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]

Co-Diagnostics, Inc.  (CODX) 
US:NASDAQ Investor Relations: ir.codiagnostics.com/investor-relations
PDF US$0.25 loss per share (improved from US$0.31 loss in 2Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Co-Diagnostics Reven [Read more]